Skip to main content

KROS

Keros Therapeutics, Inc.

Company with tickers: KROS

CIK
1664710
CUSIP
492327101
Shares Outstanding
19,791,837
13F Activity (30d)
42 filings 39 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$375,000,000
as of 2025-10-20
Fiscal Year Ended Cash Spent
2025-12-31 $375,000,000
2024-12-31 $0